XML 29 R45.htm IDEA: XBRL DOCUMENT v3.2.0.727
LONG-TERM DEBT (Details Textual) - USD ($)
3 Months Ended 12 Months Ended
Dec. 03, 2013
Feb. 04, 2013
Mar. 31, 2015
Mar. 31, 2014
Dec. 31, 2014
Dec. 31, 2013
Mar. 31, 2012
Interest Expense     $ 141,000 $ 5,552,000      
Proceeds from Issuance of Long-term Debt     $ 3,293,000   $ 3,717,000    
Debt Financing Facility Agreement Amount $ 5,000,000 $ 15,000,000          
Facility Agreement [Member]              
Fair Value Inputs, Discount Rate   20.00%          
Premium On Reimbursement   $ 2,600,000          
Interest Expense 2,200,000 2,500,000          
Debt Financing Facility Agreement Amount 15,000,000 15,000,000          
Fund Raised From Debt Financing Facility 2,800,000 12,400,000          
Initial Loan Amount 5,000,000            
Additional Loan Amount 5,000,000            
Debt Financing Nominal Value $ 5,000,000            
Debt Repayment Term Jan. 31, 2017            
Royalty Agreement [Member]              
Fund Raised From Debt Financing Facility $ 2,200,000 $ 2,600,000          
Long Term Debt Repayment Percentage 0.834% 1.75%          
Debt Repayment Term Dec. 31, 2024 Dec. 31, 2024          
Deerfield Facility Agreement [Member]              
Debt Repayment Term Mar. 24, 2014            
Broadfin Facility Agreement [Member]              
Debt Repayment Term   Mar. 24, 2014          
Eclat Pharmaceuticals [Member]              
Percentage Of Earn Out Payment     20.00%     20.00%  
Eclat Pharmaceuticals [Member] | Senior Secured Six Year Note [Member]              
Secured Debt     $ 12,000,000       $ 12,000,000
Interest Expense     $ 3,000,000        
American Depository Shares [Member]              
Class of Warrant or Right, Number of Securities Called by Warrants or Rights     3,300,000